An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
Trial details
- Registry ID
- NCT07102459
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| An Efficacy and Safety Study of LTG-001 Following AbdominoplastyNCT07102459 | Latigo Biotherapeutics | Phase 2 | Completed | 2026-01-07Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |